Digital pathology, also known as virtual pathology, is a rapidly growing sub-field of pathology that is revolutionizing the way pathologists diagnose, analyze, and report on tissue slides. Digital pathology combines the power of imaging technology, computer-aided diagnosis (CAD) algorithms, and the Internet to provide a new way to view, store, and share tissue slides. The digital pathology market is expected to grow significantly over the next few years, as more and more organizations begin to adopt digital pathology technology.
According to a recent report, the global Digital Pathology Market is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, rising incidence of cancer, and growing applications of digital pathology in drug development and companion diagnostics.
The digital pathology market is driven by a number of factors, including the increasing need for accuracy and efficiency in pathology, the growing availability of digital pathology systems, and the increasing demand for more comprehensive and cost-effective diagnostic solutions. Additionally, the advancement of digital pathology technology is allowing for more efficient and accurate diagnosis of diseases, which is helping to drive the growth of the market.
The digital pathology market is composed of a number of different segments, including pathology software, pathology viewers, pathology-as-a-service (PaaS), and digital pathology systems. Each of these segments offers different products, services, and solutions that are designed to meet the needs of different organizations. For example, pathology software can be used to analyze, store, and share digital images, while pathology viewers can be used to display digital slides in an easy-to-understand format.
Request for assumptions how numbers were triangulated.
https://www.marketsandmarkets.com/requestsampleNew.asp?id=844
The digital pathology market is expected to experience significant growth over the next few years, as organizations continue to adopt digital pathology technology. This is due to the increasing demand for more accurate and cost-effective diagnostic solutions, the growing availability of digital pathology systems, and the advancement of digital pathology technology. As such, the digital pathology market is expected to continue to grow in the coming years.
The global digital pathology market is highly competitive, with a number of players operating in the market. Some of the major players in the market include Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics (Japan)were the top players in the Digital Pathology market during the forecast period. Other major players in the market include Sectra AB (Sweden), F. Hoffmann-La Roche Ltd. (Switzerland), Visiopharm A/S (Denmark), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Corista (US), Indica Labs (US), OptraSCAN (India), Glencoe Software (US), Inspirata (US), Mikroscan Technologies (US), and Kanteron Systems (Spain).
Download an Illustrative Overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=844
Recent Developments
- In September 2021, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) collaborated to co-market Visiopharm’s portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent’s automated pathology staining solutions portfolio.
- In August 2021, Sectra AB (Sweden) and University Medical Center Utrecht (Netherlands) signed an agreement under which UMC uses Sectra’s pathology module for effective multidisciplinary discussions among pathologists and radiologists.
- In May 2021, Sectra AB (Sweden) and Institut Curie (France) signed an agreement which allows the digitization of pathology at Institut Curie. The pathologists in Institut Curie can access cases, digital tools, and AI applications through the Sectra pathology solution.
- In April 2021, Leica Biosystems (US) and Paige.AI, Inc. (US) partnered for Paigersquo;s AI-enabled research software for tumor detection, grading, and quantification to Leica Biosystems digital pathology platform in countries throughout North America and Europe.
Content Source:
https://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-844.html
